NCT05045378View on ClinicalTrials.gov

Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Treatment-resistant DepressionMajor Depressive Disorder
Interventions
DRUG

Midazolam (active placebo)

Arm1: Two 0.045mg/kg midazolam infusions at Day1 and Day3。

DRUG

Ketamine and Midazolam (active placebo)

Arm2: First 0.045mg/kg midazolam infusion and Second 0.5mg/kg ketamine infusion。

DRUG

Ketamine

Arm3: Two 0.5mg/kg ketamine infusions。

Trial Locations (1)

112

Taipei Veterans General Hospital, Taiwan, Taipei

All Listed Sponsors
lead

Taipei Veterans General Hospital, Taiwan

OTHER_GOV